Tumour – Gliomas 2
Functional characterisation of the growth factor Midkine in glioma cells
Influence of glycation on the treatment response of glioma cells to tumour treating fields (TTFields, Optune)
Investigating the surgical treatment course of glioblastoma patients aged 70 or older
Longitudinal analysis of the immune landscape in recurrent glioblastoma – Infiltration of natural killer cells and TCR clonality as biomarkers of overall survival
Metabolome profile in cerebrospinal fluid and serum of patients with diffuse glioma
MicroRNAs in native tumor tissue and primary tumor cell cultures of glioblastomas as biomarkers for therapy response to tumor treating fields in vitro